Tag: U.K.
-
Biotechs Partner to Boost mRNA Manufacturing
Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing.
-
HPV Vaccine Generates Immune Responses in Trial
Early results from a clinical trial show a vaccine for the human papillomavirus is safe and invokes immune responses in women with low-grade cervical lesions.
-
Business-Academic Team to Create RNA Delivery for Cancer
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles.
-
Bio-Electric Regeneration Company Adds $8M in Seed Funds
A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds.
-
Nasal Spray Reduces Flu Duration in Challenge Trial
An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus.
-
Trial Underway Testing Bioelectronic Incontinence Device
The first participants are enrolled in a clinical trial of an implanted bio-feedback device to help women control urinary incontinence, sudden or stress-related urges to urinate.
-
Project to Sequence 20K Dog and Cat Genomes
Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets.
-
BioNTech to Provide Personal Cancer Immunotherapies in UK
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030.
-
New Company Creating High-Capacity Gene Therapies to the Brain
A new business is underway developing gene therapies with higher capacities than most current technologies to treat neurodegenerative disorders.
-
Mental Health VR Companies Merge, Raise $13M
Two developers of virtual reality therapy technology for mental health disorders are combining their operations, and raising $13 million in venture funds.